Figure 1From: Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation Change in signs and symptoms of acromegaly reported in the RCT. Mean and 95% confidence intervals of change at 12 weeks relative to baseline. Raw data taken from Trainer 2000 [7].Back to article page